Press Release

Cooley Advises on the Formation of Helix, a New Consumer Genomics Platform Venture

September 24, 2015

San Diego – September 24, 2015 – Cooley is advising Warburg Pincus and Sutter Hill on the formation and commercialization arrangements for Helix, a $100 million new venture with Illumina. Cooley will continue as an advisor to the new venture.

The new venture, Helix, will enable individuals to acquire an unprecedented amount of genetic information. By providing affordable sequencing and database services for consumer samples brought through third party partners, Helix will drive the creation of an ecosystem of consumer applications, according to Warburg Pincus.

The team advising Warburg Pincus is led by partners Wainwright Fishburn and Glen Sato and includes senior associate Holly Holloway.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900+ lawyers across 13 offices in the United States, China and Europe.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.